Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Power List / 2025 / Advanced Medicine / Stella Vnook

Stella Vnook

CEO, Likarda

  • Profile

Meet Stella Vnook

Stella joined Likarda in 2023 to oversee a rapid pivot and expansion into multiple areas after recognizing a broad list of applications for the company’s Core Shell Spherification technology. From humble beginnings in Belarus, Stella arrived in the US as a teenager, and has now founded, led, and sat on the board of numerous biopharma companies. A regular keynote speaker and Penn State University-based mentor, Stella makes a second consecutive appearance on the Power List.

“My motivation is not just in developing new therapies but also in streamlining the pathway from discovery to patient access. The potential for cell and gene therapies to offer one-time, life-changing treatments instead of lifelong disease management is a paradigm shift that I am committed to advancing.”

Recommended

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.